Document

Center for Biologics Evaluation and Research Medical Device Action Plan; Public Meeting; Correction

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of November 2, 1998 (63 FR 58743). The document announced an upcoming public ...

[Federal Register Volume 63, Number 227 (Wednesday, November 25, 1998)]
[Notices]
[Pages 65212-65213]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-31412]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 98N-1002]


Center for Biologics Evaluation and Research Medical Device 
Action Plan; Public Meeting; Correction

Agency

Food and Drug Administration, HHS.

Action

Notice of meeting; correction.

-----------------------------------------------------------------------

Summary

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of November 2, 1998 (63 FR 58743). The document announced an upcoming public meeting requesting suggestions for improvements to the Center for Biologics Evaluation and Research's regulation of medical devices or reasons to maintain the current systems to protect public health. The notice inadvertently omitted the date and addresses for the submissions of comments after the meeting. This document corrects those omissions.

For Further Information Contact

Kathy A. Eberhart, Center for Biologics Evaluation and Research (HFM-43), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852-1448, 301-827- 1317.

Supplementary Information

In the Federal Register of November 2, 1998 (63 FR 58743), in FR Doc. 98-29185, FDA announced an upcoming public meeting requesting suggestions for improvements to the the Center for Biologics Evaluation and Research's regulations of medical devices or reasons to maintain the current systems to protect public health. The notice inadvertently omitted the date and address for the submissions of comments after the meeting. 1. On page 58743, in the third column, under the Date and Time caption, a second sentence is added to read ``Submit written comments by December 22, 1998.'' 2. On the same page, after the ``Location'' portion, another paragraph is added to read ``Addresses: Submit by December 22, 1998, written comments to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Two copies of any comments are to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number found in brackets in the heading of this document. A copy and received comments are available for public

examination in the Dockets Management Branch between 9 a.m. and 4 p.m., Monday through Friday.''

Dated: November 18, 1998. William K. Hubbard, Associate Commissioner for Policy Coordination. [FR Doc. 98-31412 Filed 11-24-98; 8:45 am] BILLING CODE 4160-01-F

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

63 FR 65212

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Center for Biologics Evaluation and Research Medical Device Action Plan; Public Meeting; Correction,” thefederalregister.org (November 25, 1998), https://thefederalregister.org/documents/98-31412/center-for-biologics-evaluation-and-research-medical-device-action-plan-public-meeting-correction.